RNS Number : 6903U
Legal & General UCITS ETF PLC
30 July 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
30/07/2020 |
IE00BFXR5Q31 |
12167267 |
USD |
149167739.40 |
12.260 |
| L&G UK Equity UCITS ETF |
30/07/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10635664.80 |
8.863 |
| L&G Global Equity UCITS ETF |
30/07/2020 |
IE00BFXR5S54 |
2900000 |
USD |
34081947.12 |
11.752 |
| L&G Japan Equity UCITS ETF |
30/07/2020 |
IE00BFXR5T61 |
11185000 |
USD |
118490624.17 |
10.594 |
| L&G Europe ex UK Equity UCITS ETF |
30/07/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
100238797.64 |
10.708 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
30/07/2020 |
IE00BFXR5W90 |
5181427 |
USD |
55182307.65 |
10.650 |
| L&G Clean Water UCITS ETF |
30/07/2020 |
IE00BK5BC891 |
1500000 |
USD |
16416148.19 |
10.944 |
| L&G Artificial Intelligence UCITS ETF |
30/07/2020 |
IE00BK5BCD43 |
7946000 |
USD |
109190951.31 |
13.742 |
| L&G Healthcare Innovation UCITS ETF |
30/07/2020 |
IE00BK5BC677 |
3000000 |
USD |
41486058.31 |
13.829 |
| L&G Pharma Breakthrough UCITS ETF |
30/07/2020 |
IE00BF0H7608 |
2150000 |
USD |
26054041.49 |
12.118 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
30/07/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
93136684.72 |
10.124 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
30/07/2020 |
IE00BKLWY790 |
57800000 |
USD |
639254361.39 |
11.060 |
| L&G Battery Value-Chain UCITS ETF |
30/07/2020 |
IE00BF0M2Z96 |
13200000 |
USD |
134502524.62 |
10.190 |
| L&G Ecommerce Logistics UCITS ETF |
30/07/2020 |
IE00BF0M6N54 |
9600000 |
USD |
109170149.37 |
11.372 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
30/07/2020 |
IE00BMW3QX54 |
46830616 |
USD |
856993749.49 |
18.300 |
| L&G Cyber Security UCITS ETF |
30/07/2020 |
IE00BYPLS672 |
82611776 |
USD |
1680999664.07 |
20.348 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVKZGFNZGRGGZZ
